The effect of factors released by tumor cells on OCLs is mediated by receptor activator of nuclear factor-κB (NF-κB) ligand (RANKL), which is secreted by bone marrow mesenchymal stem cells [5]. This evidence concerns the gene TNFSF11 and neoplasm.